SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 342 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,877,014 | +5.9% | 97,979 | +0.0% | 0.06% | +11.3% |
Q2 2023 | $11,220,326 | -72.3% | 97,977 | -66.7% | 0.05% | -73.8% |
Q1 2023 | $40,550,964 | +94.5% | 294,210 | +82.9% | 0.20% | +74.1% |
Q4 2022 | $20,845,405 | +186.6% | 160,869 | +144.5% | 0.12% | +197.4% |
Q3 2022 | $7,274,000 | +411.2% | 65,803 | +246.5% | 0.04% | +457.1% |
Q2 2022 | $1,423,000 | -86.5% | 18,990 | -85.9% | 0.01% | -88.3% |
Q1 2022 | $10,558,000 | -19.3% | 135,151 | -7.0% | 0.06% | -16.7% |
Q4 2021 | $13,086,000 | -21.9% | 145,322 | -19.7% | 0.07% | -33.3% |
Q3 2021 | $16,745,000 | -35.6% | 181,067 | -45.9% | 0.11% | -40.0% |
Q2 2021 | $26,002,000 | -34.4% | 334,471 | -37.1% | 0.18% | -37.9% |
Q1 2021 | $39,647,000 | +745.7% | 531,955 | +1719.3% | 0.29% | +437.0% |
Q2 2020 | $4,688,000 | -46.0% | 29,240 | -74.6% | 0.05% | -64.2% |
Q3 2019 | $8,682,000 | +95.5% | 115,270 | +183.3% | 0.15% | -24.9% |
Q4 2018 | $4,440,000 | -75.5% | 40,684 | -70.3% | 0.20% | -58.6% |
Q2 2018 | $18,124,000 | +47.4% | 137,118 | -17.4% | 0.49% | +67.6% |
Q1 2018 | $12,296,000 | +42.2% | 165,966 | +6.8% | 0.29% | +54.3% |
Q4 2017 | $8,647,000 | +97.6% | 155,404 | -2.6% | 0.19% | +100.0% |
Q4 2016 | $4,377,000 | +1828.2% | 159,580 | +4213.0% | 0.09% | +1780.0% |
Q3 2016 | $227,000 | -81.4% | 3,700 | -90.3% | 0.01% | -91.2% |
Q3 2015 | $1,220,000 | – | 37,997 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |